LS Investment Advisors’s Acorda Therapeutics ACOR Stock Holding History

LS Investment Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12	Closed	-$1K	–	1733
2020 Q1	$1K	Hold	12	–	–	﹤0.01%	1719
2019 Q4	$3K	Hold	12	–	–	﹤0.01%	1716
2019 Q3	$4K	Hold	12	–	–	﹤0.01%	1702
2019 Q2	$11K	Hold	12	–	–	﹤0.01%	1632
2019 Q1	$19K	Hold	12	–	–	﹤0.01%	1527
2018 Q4	$22K	Sell	12 -1	-8%	-$2.18K	﹤0.01%	1473
2018 Q3	$30K	Hold	13	–	–	﹤0.01%	1482
2018 Q2	$44K	Hold	13	–	–	﹤0.01%	1359
2018 Q1	$36K	Buy	13 +1	+8%	+$2.99K	﹤0.01%	1396
2017 Q4	$31K	Sell	12 -3	-20%	-$8.53K	﹤0.01%	1444
2017 Q3	$42K	Hold	15	–	–	﹤0.01%	1411
2017 Q2	$35K	Hold	15	–	–	﹤0.01%	1453
2017 Q1	$37K	Sell	15 -1	-6%	-$2.88K	﹤0.01%	1423
2016 Q4	$36K	Hold	16	–	–	﹤0.01%	1385
2016 Q3	$40K	Hold	16	–	–	﹤0.01%	1310
2016 Q2	$49K	Buy	16 +1	+7%	+$3.25K	﹤0.01%	1219
2016 Q1	$47K	Buy	15 +1	+7%	+$4.15K	﹤0.01%	1199
2015 Q4	$70K	Hold	14	–	–	0.01%	1004
2015 Q3	$44K	Buy	14 +1	+8%	+$3.88K	﹤0.01%	1196
2015 Q2	$52K	Buy	+13	New	+$50.2K	﹤0.01%	1154

Other funds holding ACOR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LS Investment Advisors's ACOR Position: Q2 2020 in Review

LS Investment Advisors sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 12 shares — an estimated $1K sold.

LS Investment Advisors first reported a position in ACOR in Q2 2015 and held it in 20 quarters. The position peaked at $70K in Q4 2015. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.

LS Investment Advisors reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
LS Investment Advisors sold 12 Acorda Therapeutics shares in Q2 2020, an estimated $1K.
LS Investment Advisors first reported a position in Acorda Therapeutics in Q2 2015 and held it in 20 quarters.
LS Investment Advisors's Acorda Therapeutics position peaked at $70K in Q4 2015.
79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.

Based on LS Investment Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.